Mylan Offers Mega-Deal For Perrigo Just Months After Closing Inversion

April 8, 2015 4:56 PM

55 0

Mylan Offers Mega-Deal For Perrigo Just Months After Closing Inversion

Just months after closing a $5.3 billion purchase of the non-U.S. and generics businesses of Abbott Laboratories Abbott Laboratories, which shifted its tax headquarters to the Netherlands, drug maker Mylan Mylan is offering to buy competitor Perrigo Perrigo for $205 a share in a cash and stock takeover.

The prospective deal is reflective of a merger and acquisition craze in the healthcare and pharmaceutical sector as companies look to wrench out cost synergies through consolidation, and find benefits from moving their corporate headquarters to low tax jurisdictions. Those bottom-line focused M&A ef...

Read more

To category page

Loading...